- Home
- LAZR vs PRQR Comparison
LAZR vs PRQR Comparison
Compare LAZR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAZR | PRQR |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 250.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | LAZR | PRQR |
|---|---|---|
| Price | $0.20 | $2.10 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $1.00 | ★ $8.14 |
| AVG Volume (30 Days) | ★ 10.8M | 591.4K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,753,000.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.97 | N/A |
| 52 Week Low | $0.18 | $1.07 |
| 52 Week High | $10.40 | $3.10 |
Technical Indicators
Market Signals| Indicator | LAZR | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 24.43 | 44.60 |
| Support Level | $0.18 | $2.15 |
| Resistance Level | $1.04 | $2.49 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 2.37 | 33.91 |
Price Performance
Historical ComparisonAbout LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.